Yong Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yong Sun has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Aimin Li
Institute of Neuroscience, Department of Neurosurgery, Lianyungang Clinical College of Nanjing Medical University, The First Affiliated Hospital of Kangda College of Nanjing Medical University, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang 222002, China; Lianyungang Medical-Education Innovation and Research Center, Nanjing Medical University, Lianyungang 222002, China
3 shared publications Baihao Zhang
Institute of Neuroscience, Department of Neurosurgery, Lianyungang Clinical College of Nanjing Medical University, The First Affiliated Hospital of Kangda College of Nanjing Medical University, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang 222002, China
3 shared publicationsPanpan Zhao
Institute of Neuroscience, Department of Neurosurgery, Lianyungang Clinical College of Nanjing Medical University, The First Affiliated Hospital of Kangda College of Nanjing Medical University, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang 222002, China; Lianyungang Medical-Education Innovation and Research Center, Nanjing Medical University, Lianyungang 222002, China
3 shared publicationsZhengqian Huang
Department of Neurosurgery, Institute of Neuroscience, The First People’s Hospital of Lianyungang City, Lianyungang, China
3 shared publicationsBoran Hu
Institute of Neuroscience, Department of Neurosurgery, Lianyungang Clinical College of Nanjing Medical University, The First Affiliated Hospital of Kangda College of Nanjing Medical University, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang 222002, China
2 shared publications- Caihong Gu
Department of Critical Care Medicine, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, China
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Springer Nature in Lipids in Health and Disease
Association between the WBC/HDL ratio and incident stroke in middle-aged and older adults: a longitudinal study from CHARLS
- 5 October 2026
- Published by Springer Nature in Lipids in Health and Disease
Open AccessAssociation between the WBC/HDL ratio and incident stroke in middle-aged and older adults: a longitudinal study from CHARLS
- 30 May 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 112 (2) , 899-910
Multimodal machine learning for early risk stratification of post-stroke cognitive impairment
Background: Post-stroke cognitive impairment (PSCI) is a major vascular contributor to dementia, significantly impacting long-term recovery and quality of life. Developing accurate prediction models are essential for early identification and timely intervention in high-risk individuals. Objective: To develop and validate a stacking-based multimodal machine learning model integrating clinical, demographic, and neuroimaging features for early PSCI prediction in acute ischemic stroke (AIS) patients. Methods: In this retrospective cohort study, 1070 AIS patients admitted to Lianyungang First People's Hospital from January 2020 to August 2023 were included. Demographic, clinical, and neuroimaging data were collected, and cognitive function was assessed 3–6 months post-stroke. PSCI was defined as a z-score ≤ -2.0 in at least one of four cognitive domains. A stacking ensemble model was developed, combining six base algorithms: XGBoost, Gradient Boosting Decision Trees, CatBoost, Support Vector Machine, Logistic Regression, and LightGBM. The final prediction was generated by a meta-model trained on base model outputs. Results: Of the 1070 patients (mean age 67.4 ± 9.3 years, 61.5% male), 37.2% developed PSCI. The stacking model achieved 98.13% accuracy, 0.9972 AUC, and 0.9744 F1-score in internal validation. External validation showed 81.00% accuracy, 0.9049 AUC, and 0.8780 recall. Key predictors of PSCI included infarct volume, cortical lesions, medial temporal lobe atrophy, and baseline NIHSS score. Conclusions: This stacking-based multimodal machine learning model demonstrates robust predictive performance for PSCI risk in AIS patients, serving as a reliable tool for early detection that may inform personalized intervention strategies to prevent progression to post-stroke dementia.
- 30 May 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 112 (2) , 899-910
Multimodal machine learning for early risk stratification of post-stroke cognitive impairment
Background: Post-stroke cognitive impairment (PSCI) is a major vascular contributor to dementia, significantly impacting long-term recovery and quality of life. Developing accurate prediction models are essential for early identification and timely intervention in high-risk individuals. Objective: To develop and validate a stacking-based multimodal machine learning model integrating clinical, demographic, and neuroimaging features for early PSCI prediction in acute ischemic stroke (AIS) patients. Methods: In this retrospective cohort study, 1070 AIS patients admitted to Lianyungang First People's Hospital from January 2020 to August 2023 were included. Demographic, clinical, and neuroimaging data were collected, and cognitive function was assessed 3–6 months post-stroke. PSCI was defined as a z-score ≤ -2.0 in at least one of four cognitive domains. A stacking ensemble model was developed, combining six base algorithms: XGBoost, Gradient Boosting Decision Trees, CatBoost, Support Vector Machine, Logistic Regression, and LightGBM. The final prediction was generated by a meta-model trained on base model outputs. Results: Of the 1070 patients (mean age 67.4 ± 9.3 years, 61.5% male), 37.2% developed PSCI. The stacking model achieved 98.13% accuracy, 0.9972 AUC, and 0.9744 F1-score in internal validation. External validation showed 81.00% accuracy, 0.9049 AUC, and 0.8780 recall. Key predictors of PSCI included infarct volume, cortical lesions, medial temporal lobe atrophy, and baseline NIHSS score. Conclusions: This stacking-based multimodal machine learning model demonstrates robust predictive performance for PSCI risk in AIS patients, serving as a reliable tool for early detection that may inform personalized intervention strategies to prevent progression to post-stroke dementia.
- 9 May 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 253, 108-130
Fyn promotes NLRP3 inflammasome activation in microglia and exacerbates early brain injury following subarachnoid hemorrhage
- 9 May 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 253, 108-130
Fyn promotes NLRP3 inflammasome activation in microglia and exacerbates early brain injury following subarachnoid hemorrhage
- 16 December 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 301
Atraric Acid Ameliorates Neurological Dysfunction in High-Fat Diet-Fed Mice by Activating Autophagy to Alleviate Brain Oxidative Stress and Neuroinflammation
The ability of atraric acid (AA), a lichen-derived metabolite with anti-inflammatory/antioxidant properties, to protect against obesity-associated neurological dysfunctions was investigated given the role of obesity in triggering neuroinflammation via free fatty acids. Model mice were fed a high-fat diet (HFD) for 12 weeks, and HT22 neurons were exposed to oleic acid/palmitic acid (OA/PA). A variety of experimental techniques, including CCK8, H&E staining, Nissl staining, QPCR, and behavioral tests (open field, elevated plus maze, and Morris water maze), have been used to assess cognitive/anxiety phenotypes. Molecular analyses, including ELISAs (TNF-α/IL-6/GM-CSF), biochemical assays (oxidative stress markers), immunofluorescence/Western blotting, H2DCFDA-based ROS quantification, and 3-methyladenine (3MA) autophagy blockade, were also performed. The results revealed that AA effectively alleviated anxiety- and depression-like behaviors in HFD-fed mice, as demonstrated by the results of open field and elevated plus-maze tests. AA also significantly mitigated the cognitive decline observed in behavioral assessments, such as the Morris water maze test. Furthermore, AA protected against structural damage and neuronal death in the hippocampal CA1 region. ELISAs and biochemical assays revealed that increasing concentrations of atraric acid significantly reduced the levels of the neuronal injury markers NSE and S100β, as well as the proinflammatory cytokines TNF-α, IL-6, and GM-CSF. Western blot analysis confirmed that AA activated autophagy via the mTOR signaling pathway, thereby reducing oxidative stress, attenuating neuroinflammation, and ultimately improving cognitive impairment in mice. In conclusion, this study demonstrated that the protective effect of AA against HFD-induced cognitive impairment is associated with the activation of autophagy, a reduction in oxidative stress, and the alleviation of neuroinflammation. Our findings demonstrate the neuroprotective properties of atraric acid in preclinical models, providing a rationale for further investigation as a potential candidate for treating cognitive dysfunction.
- 16 December 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 301
Atraric Acid Ameliorates Neurological Dysfunction in High-Fat Diet-Fed Mice by Activating Autophagy to Alleviate Brain Oxidative Stress and Neuroinflammation
The ability of atraric acid (AA), a lichen-derived metabolite with anti-inflammatory/antioxidant properties, to protect against obesity-associated neurological dysfunctions was investigated given the role of obesity in triggering neuroinflammation via free fatty acids. Model mice were fed a high-fat diet (HFD) for 12 weeks, and HT22 neurons were exposed to oleic acid/palmitic acid (OA/PA). A variety of experimental techniques, including CCK8, H&E staining, Nissl staining, QPCR, and behavioral tests (open field, elevated plus maze, and Morris water maze), have been used to assess cognitive/anxiety phenotypes. Molecular analyses, including ELISAs (TNF-α/IL-6/GM-CSF), biochemical assays (oxidative stress markers), immunofluorescence/Western blotting, H2DCFDA-based ROS quantification, and 3-methyladenine (3MA) autophagy blockade, were also performed. The results revealed that AA effectively alleviated anxiety- and depression-like behaviors in HFD-fed mice, as demonstrated by the results of open field and elevated plus-maze tests. AA also significantly mitigated the cognitive decline observed in behavioral assessments, such as the Morris water maze test. Furthermore, AA protected against structural damage and neuronal death in the hippocampal CA1 region. ELISAs and biochemical assays revealed that increasing concentrations of atraric acid significantly reduced the levels of the neuronal injury markers NSE and S100β, as well as the proinflammatory cytokines TNF-α, IL-6, and GM-CSF. Western blot analysis confirmed that AA activated autophagy via the mTOR signaling pathway, thereby reducing oxidative stress, attenuating neuroinflammation, and ultimately improving cognitive impairment in mice. In conclusion, this study demonstrated that the protective effect of AA against HFD-induced cognitive impairment is associated with the activation of autophagy, a reduction in oxidative stress, and the alleviation of neuroinflammation. Our findings demonstrate the neuroprotective properties of atraric acid in preclinical models, providing a rationale for further investigation as a potential candidate for treating cognitive dysfunction.
- Open Access
- 28 October 2025
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (6) , 2035-2046
High Apolipoprotein B Levels are Associated with an Increased Risk of Recurrent Acute Ischemic Stroke: A Nested Case–Control Study
Mendelian randomization studies have identified that apolipoprotein B (ApoB) is the primary genetic determinant of ischemic stroke, rather than other lipid
- 28 October 2025
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (6) , 2035-2046
Open AccessHigh Apolipoprotein B Levels are Associated with an Increased Risk of Recurrent Acute Ischemic Stroke: A Nested Case–Control Study
Mendelian randomization studies have identified that apolipoprotein B (ApoB) is the primary genetic determinant of ischemic stroke, rather than other lipid
- Open Access
- 18 June 2025
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 45 (1) , 1-17
Senolytic Treatment Attenuates Global Ischemic Brain Injury and Enhances Cognitive Recovery by Targeting Mitochondria
The benefits of senolytic therapy have been known in a series of age-related diseases, whereas its potential roles in global cerebral ischemic (GCI) brain injury remain unexplored. In current study, we aim to investigate the effects of combined senolytics Dasatinib plus Quercetin (D&Q) treatment in GCI and the underlying mechanisms in a mouse model. We firstly report that 12-week post-GCI D&Q treatment effectively eliminated cellular senescence of astrocytes and microglia in the hippocampus of mice brain, followed by decreased release of the potent inflammatory senescence-associated secretory phenotypes (SASP). Further mechanistic analysis suggested that D&Q administration can effectively regulate mitochondrial function as a critical downstream target. D&Q treatment inhibited GCI-induced mitochondrial fragmentation and maintained mitochondrial integrity. Subsequently, D&Q treatment improved the mitochondrial metabolic function by enhancing mitochondrial cytochrome c oxidase (CCO) activity and ATP production. Moreover, D&Q treatment reversed the decline of mitochondrial antioxidant enzyme SOD2 and reduced the ROS accumulation and suppressed oxidative damage to cellular protein structure. Further investigation indicated D&Q treatment protected the hippocampal neurons after GCI by mitigating the dendritic injury and neuronal apoptotic signaling. Extensive behavioral tests assessed the functional outcomes and showed that D&Q treatment effectively preserved hippocampus-dependent spatial reference memory and recognition memory, and mitigated GCI-induced anxiety and depression levels. Taken together, our study provides leading evidence for the neuroprotective roles of the senolytics D&Q in GCI model and identifies regulation of mitochondrial functions could be the key underlying mechanism. These findings offer novel insights into the potential clinical applications of senolytic agents in therapy. Graphical Abstract
- 18 June 2025
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 45 (1) , 1-17
Open AccessSenolytic Treatment Attenuates Global Ischemic Brain Injury and Enhances Cognitive Recovery by Targeting Mitochondria
The benefits of senolytic therapy have been known in a series of age-related diseases, whereas its potential roles in global cerebral ischemic (GCI) brain injury remain unexplored. In current study, we aim to investigate the effects of combined senolytics Dasatinib plus Quercetin (D&Q) treatment in GCI and the underlying mechanisms in a mouse model. We firstly report that 12-week post-GCI D&Q treatment effectively eliminated cellular senescence of astrocytes and microglia in the hippocampus of mice brain, followed by decreased release of the potent inflammatory senescence-associated secretory phenotypes (SASP). Further mechanistic analysis suggested that D&Q administration can effectively regulate mitochondrial function as a critical downstream target. D&Q treatment inhibited GCI-induced mitochondrial fragmentation and maintained mitochondrial integrity. Subsequently, D&Q treatment improved the mitochondrial metabolic function by enhancing mitochondrial cytochrome c oxidase (CCO) activity and ATP production. Moreover, D&Q treatment reversed the decline of mitochondrial antioxidant enzyme SOD2 and reduced the ROS accumulation and suppressed oxidative damage to cellular protein structure. Further investigation indicated D&Q treatment protected the hippocampal neurons after GCI by mitigating the dendritic injury and neuronal apoptotic signaling. Extensive behavioral tests assessed the functional outcomes and showed that D&Q treatment effectively preserved hippocampus-dependent spatial reference memory and recognition memory, and mitigated GCI-induced anxiety and depression levels. Taken together, our study provides leading evidence for the neuroprotective roles of the senolytics D&Q in GCI model and identifies regulation of mitochondrial functions could be the key underlying mechanism. These findings offer novel insights into the potential clinical applications of senolytic agents in therapy. Graphical Abstract
- 27 May 2025
- Published by Springer Nature in Neuroscience Bulletin
- p. 1-19
WNK1 Alleviates Chloride Efflux-Induced NLRP3 Inflammasome Activation and Subsequent Neuroinflammation in Early Brain Injury Following Subarachnoid Hemorrhage
The nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome plays a crucial role in the prognosis of subarachnoid hemorrhage (SAH). WNK1 kinase negatively regulates NLRP3 in various inflammatory conditions, but its role in early brain injury (EBI) after SAH remains unclear. In this study, we used an in vivo SAH model in rats/mice and AAV-WNK1 intraventricular injection to investigate its neuroprotective mechanisms. WNK1 expression was significantly reduced in SAH patient blood and SAH model brain tissue, correlating negatively with microglial activation. AAV-WNK1 alleviated brain edema, neuronal necrosis, behavioral deficits, and inflammation by inhibiting NLRP3 inflammasome activation. In hemin-stimulated BV-2 cells, WNK1 overexpression reduced NLRP3 activation and inflammatory cytokines. Chloride counteracted WNK1’s inhibitory effects, and WNK1 suppressed P2X7R-induced NLRP3 activation. Mechanistically, WNK1 functioned via the OXSR1/STK39 pathway. These findings highlight WNK1 as a key regulator of intracellular chloride balance and neuroinflammation, presenting a potential therapeutic target for SAH treatment.
- 27 May 2025
- Published by Springer Nature in Neuroscience Bulletin
- p. 1-19
WNK1 Alleviates Chloride Efflux-Induced NLRP3 Inflammasome Activation and Subsequent Neuroinflammation in Early Brain Injury Following Subarachnoid Hemorrhage
The nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome plays a crucial role in the prognosis of subarachnoid hemorrhage (SAH). WNK1 kinase negatively regulates NLRP3 in various inflammatory conditions, but its role in early brain injury (EBI) after SAH remains unclear. In this study, we used an in vivo SAH model in rats/mice and AAV-WNK1 intraventricular injection to investigate its neuroprotective mechanisms. WNK1 expression was significantly reduced in SAH patient blood and SAH model brain tissue, correlating negatively with microglial activation. AAV-WNK1 alleviated brain edema, neuronal necrosis, behavioral deficits, and inflammation by inhibiting NLRP3 inflammasome activation. In hemin-stimulated BV-2 cells, WNK1 overexpression reduced NLRP3 activation and inflammatory cytokines. Chloride counteracted WNK1’s inhibitory effects, and WNK1 suppressed P2X7R-induced NLRP3 activation. Mechanistically, WNK1 functioned via the OXSR1/STK39 pathway. These findings highlight WNK1 as a key regulator of intracellular chloride balance and neuroinflammation, presenting a potential therapeutic target for SAH treatment.
- 8 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11935-11947
SCD1-Mediated Lipid Metabolism Alleviates Neuronal Ferroptosis in Subarachnoid Hemorrhage: Role of Oleic Acid Supplementation
Subarachnoid hemorrhage (SAH) can cause severe neuronal damage and trigger multiple molecular mechanisms of cell death, among which ferroptosis has garnered significant attention due to its dependence on lipid peroxidation. In this study, ferroptosis-related markers were found to be significantly dysregulated in an in vitro SAH model, confirming the neuronal ferroptosis after SAH. Transcriptomic sequencing results indicated a marked downregulation of stearoyl-CoA desaturase 1 (SCD1), which was further validated by Western blot. Immunofluorescence demonstrated its colocalization with the neuronal marker NeuN. Overexpression of SCD1 effectively reduced ferroptosis-related markers and mitigated intracellular lipid accumulation. Additionally, supplementation with oleic acid (OA) which was the main product of SCD1, significantly alleviated hemoglobin (Hb)-induced ferroptosis. Furthermore, the ratio of saturated fatty acids (stearic acid, SA) to unsaturated fatty acids (OA) had a significant impact on neuronal survival. When the proportion of OA was increased (SA:OA = 1:2), ferroptosis was markedly inhibited. In conclusion, this study revealed the role and mechanism by which SCD1 affected neuronal ferroptosis by regulating oleic acid metabolism after SAH, providing a new potential target for mitigating neural injury after SAH.
- 8 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11935-11947
SCD1-Mediated Lipid Metabolism Alleviates Neuronal Ferroptosis in Subarachnoid Hemorrhage: Role of Oleic Acid Supplementation
Subarachnoid hemorrhage (SAH) can cause severe neuronal damage and trigger multiple molecular mechanisms of cell death, among which ferroptosis has garnered significant attention due to its dependence on lipid peroxidation. In this study, ferroptosis-related markers were found to be significantly dysregulated in an in vitro SAH model, confirming the neuronal ferroptosis after SAH. Transcriptomic sequencing results indicated a marked downregulation of stearoyl-CoA desaturase 1 (SCD1), which was further validated by Western blot. Immunofluorescence demonstrated its colocalization with the neuronal marker NeuN. Overexpression of SCD1 effectively reduced ferroptosis-related markers and mitigated intracellular lipid accumulation. Additionally, supplementation with oleic acid (OA) which was the main product of SCD1, significantly alleviated hemoglobin (Hb)-induced ferroptosis. Furthermore, the ratio of saturated fatty acids (stearic acid, SA) to unsaturated fatty acids (OA) had a significant impact on neuronal survival. When the proportion of OA was increased (SA:OA = 1:2), ferroptosis was markedly inhibited. In conclusion, this study revealed the role and mechanism by which SCD1 affected neuronal ferroptosis by regulating oleic acid metabolism after SAH, providing a new potential target for mitigating neural injury after SAH.